Ginkgo Bioworks Holdings (DNA) Profit After Tax (QoQ) (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) Profit After Tax (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 445.24 Mn | 301.37 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -135.62% |
| Dec 31, 2025 | 387.12% |
| Sep 30, 2025 | -39.72% |
| Jun 30, 2025 | 30.62% |
| Mar 31, 2025 | -119.05% |
| Dec 31, 2024 | 875.54% |
| Sep 30, 2024 | 74.05% |
| Jun 30, 2024 | -31.01% |
| Mar 31, 2024 | 21.63% |
| Dec 31, 2023 | 30.11% |
| Sep 30, 2023 | -75.08% |
| Jun 30, 2023 | 15.18% |
| Mar 31, 2023 | -16.23% |
| Dec 31, 2022 | 73.82% |
| Sep 30, 2022 | 0.07% |
| Jun 30, 2022 | -13.56% |
| Mar 31, 2022 | 63.30% |
| Dec 31, 2021 | -1,471.18% |
| Sep 30, 2021 | -89.85% |
| Jun 30, 2021 | 26.68% |